RNN - Rexahn Pharmaceuticals, Inc. (AMEX Stock)

[greencat]

Holy gap a roo. Usually a good sign when the gap is held. I tend not to trade these set-ups.

RNN Chart


Rexahn Pharmaceuticals, Inc.
15245 Shady Grove Road
Suite 455
Rockville, MD 20850
United States - Map
Phone: 240-268-5300
Fax: 240-268-5310
Web Site: http://www.rexahn.com

DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 14


BUSINESS SUMMARY
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for cancer, central nervous system (CNS) disorders, ****** dysfunction, and other unmet medical needs in the United States. The company’s drug candidates in Phase II clinical trials include Archexin, a inhibitor of the protein kinase Akt for the treatment of renal cell carcinoma and pancreatic cancer; Serdaxin for the treatment of depression and neurodegenerative disorders; and Zoraxel, a CNS-based ****** dysfunction drug product for the treatment of ****** dysfunction. Its pre-clinical pipeline products include RX-0201-Nano, a nanoliposomal anti-cancer Akt-1 inhibitor; RX-0047-Nano, a nanoliposomal anti-cancer HIF-1 alpha inhibitor; Nano-polymer anticancer drugs; RX-0183, small molecule targeted anticancer drug candidate; RX-5902, small molecule microtubule inhibitor anticancer drug candidate; and RX-3117, small molecule anti-metabolite nucleoside anticancer drug candidate. Rexahn Pharmaceuticals has collaboration and license arrangements with UPM Pharmaceuticals, Inc.; Korean Research Institute of Bioscience and Biotechnology; Ewha Womans University; Korea Research Institute of Chemical Technology; The University of Maryland; The University of Maryland Baltimore; Revaax Pharmaceuticals LLC; Formatech, Inc.; and TheraTarget. The company is based in Rockville, Maryland.

[greencat]

RNN holding the gap and has a little triangle pattern. I think its going to make a move up out of this little consolidation.

RNN Chart